These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10431613)

  • 41. Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells.
    Lu X; McCoy KS; Xu J; Hu W; Chen H; Jiang K; Han F; Chen P; Wang Y
    Virus Res; 2015 Jan; 195():162-71. PubMed ID: 25451068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
    Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
    Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
    Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
    J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally.
    Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M
    J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
    Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
    Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvia plebeia R. Br. polysaccharides (SPP) against RSV (respiratory syncytial virus) infection: Antiviral effect and mechanisms of action.
    Liang YY; Li KW; Niu FJ; Li Y; Wei HC; Dai YL; Wang YY; Zhou CZ; Wan XH
    Biomed Pharmacother; 2021 Sep; 141():111843. PubMed ID: 34175821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
    Graham BS; Davis TH; Tang YW; Gruber WC
    Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Verapamil inhibits respiratory syncytial virus infection by regulating Ca
    Chen F; Shen H; Liu G; Zhang P; Zhang L; Lin S; Gao H; Peng H; Qi YF; Chen Y; Jiang Y; Huang J; Shen X; Luo YS; Zhang K
    Life Sci; 2024 Sep; 352():122877. PubMed ID: 38942358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.
    Shi H; Ren K; Lv B; Zhang W; Zhao Y; Tan RX; Li E
    Sci Rep; 2016 Oct; 6():35851. PubMed ID: 27767097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory syncytial virus increases lung cellular bioenergetics in neonatal C57BL/6 mice.
    Alsuwaidi AR; Albawardi A; Almarzooqi S; Benedict S; Othman AR; Hartwig SM; Varga SM; Souid AK
    Virology; 2014 Apr; 454-455():263-9. PubMed ID: 24725953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula.
    Zhou LH; Xu JY; Dai C; Fan YM; Yuan B
    Chin J Nat Med; 2018 Apr; 16(4):241-251. PubMed ID: 29703324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.
    Ottolini MG; Curtis SR; Mathews A; Ottolini SR; Prince GA
    Bone Marrow Transplant; 2002 Jan; 29(2):117-20. PubMed ID: 11850705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
    Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
    J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
    Benoit AC; Huang Y; Maneewatchararangsri S; Tapchaisri P; Anderson R
    Vaccine; 2007 Nov; 25(45):7754-62. PubMed ID: 17920164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
    Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
    Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense.
    Leaman DW; Longano FJ; Okicki JR; Soike KF; Torrence PF; Silverman RH; Cramer H
    Virology; 2002 Jan; 292(1):70-7. PubMed ID: 11878909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DSCG reduces RSV-induced illness in RSV-infected mice.
    Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
    J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.